Maximum Diameter of Prostatic Carcinoma Is a Simple, Inexpensive, and Independent Predictor of Prostate-Specific Antigen Failure in Radical Prostatectomy Specimens: Validation in a Cohort of 434 Patients (original) (raw)

Maximum tumor diameter: a simple independent predictor for biochemical recurrence after radical prostatectomy

Yukio Homma

Prostate Cancer and Prostatic Diseases, 2010

View PDFchevron_right

Radical Prostatectomy for Prostate Cancer Patients with Prostate-specific Antigen >20 ng/ml

Chi-Rei Yang

Japanese Journal of Clinical Oncology, 2003

View PDFchevron_right

Is there a prostate-specific antigen upper limit for radical prostatectomy?

Bruno Frea

BJU International, 2011

View PDFchevron_right

Tumor Volume and Prostate Specific Antigen: Implications for Early Detection and Defining a Window of Curability

Edilberto Ramirez

Journal of Urology, 1995

View PDFchevron_right

Serum Prostate-Specific Antigen (PSA) Level is a Biomarker for Prostate Adenocarcinoma Grade, Tumour Volume and Histologic Prognostic Indicators

Grace Ferguson

Acta Scientific Medical Sciences

View PDFchevron_right

Tumor extent in radical prostatectomy specimens: is it an independent prognostic factor for biochemical (PSA) progression following surgery?

Leandro Freitas

International Urology and Nephrology, 2011

View PDFchevron_right

Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels

David Paulson, Harold Frazier

Cancer, 1993

View PDFchevron_right

Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens

Thomas Wheeler

Human Pathology, 2001

View PDFchevron_right

Adverse pathology after radical prostatectomy: the prognostic role of cumulative cancer length >6-mm threshold in prostate cancer–positive biopsies

Maria Raspollini

Prostate International, 2019

View PDFchevron_right

Prostate-Specific Antigen Density Predicts Adverse Pathology and Increased Risk of Biochemical Failure

Steven Brandes

Urology, 2007

View PDFchevron_right

Prostate Cancer is Highly Predictable: A Prognostic Equation Based on All Morphological Variables in Radical Prostatectomy Specimens

Cheryl Yemoto

The Journal of Urology, 2000

View PDFchevron_right

The Significance Of Margin Involvement In Radical Prostatectomy Specimens For Presumed Localized Adenocarcinoma Of Prostate In Relation To PSA (Biochemical) Failure Rate

SARANG SHAH

2012

View PDFchevron_right

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

Yan Yan

Urology, 2002

View PDFchevron_right

PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes — Results from the SEARCH Database

Stephen Freedland

European Urology, 2008

View PDFchevron_right

Preoperative PSA Velocity Is an Independent Prognostic Factor for Relapse After Radical Prostatectomy

Harcharan Gill

Journal of Clinical Oncology, 2005

View PDFchevron_right

PERCENT FREE PROSTATE SPECIFIC ANTIGEN IS NOT AN INDEPENDENT PREDICTOR OF ORGAN CONFINEMENT OR PROSTATE SPECIFIC ANTIGEN RECURRENCE IN UNSCREENED PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY

Peter Hammerer

The Journal of Urology, 2002

View PDFchevron_right

Correlation between tumor extent in radical prostatectomies and preoperative PSA, histological grade, surgical margins, and extraprostatic extension: application of a new practical method for tumor extent evaluation

Ubirajara Ferreira

International braz j urol : official journal of the Brazilian Society of Urology

View PDFchevron_right

Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy

Michael Cookson

Urology, 1997

View PDFchevron_right

The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml

Alberto Lapini

International Urology and Nephrology, 2012

View PDFchevron_right

Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer

Peter Schiff, I-chow Hsu

Urology, 1997

View PDFchevron_right

Preoperative Serum Prostate Specific Antigen Remains a Significant Prognostic Variable In Predicting Biochemical Failure After Radical Prostatectomy

Carl Olsson

The Journal of …, 2006

View PDFchevron_right

Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer

C. Thaxton

Urology, 2008

View PDFchevron_right

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients

Dimitri Vordos

BJU International, 2011

View PDFchevron_right

Outcome of Prostate Cancer Patients with Initial PSA ≥ 20 ng/ml Undergoing Radical Prostatectomy

jan lehmann

European Urology, 2007

View PDFchevron_right

Tumor Percent Involvement Predicts Prostate Specific Antigen Recurrence After Radical Prostatectomy Only in Men With Smaller Prostate

David Albala

The Journal of Urology, 2010

View PDFchevron_right